List of Tables
Table 1. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market FMS-like Tyrosine Kinase 3 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of FMS-like Tyrosine Kinase 3 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of FMS-like Tyrosine Kinase 3 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of FMS-like Tyrosine Kinase 3 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of FMS-like Tyrosine Kinase 3 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FMS-like Tyrosine Kinase 3 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FMS-like Tyrosine Kinase 3 Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific FMS-like Tyrosine Kinase 3 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific FMS-like Tyrosine Kinase 3 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa FMS-like Tyrosine Kinase 3 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa FMS-like Tyrosine Kinase 3 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global FMS-like Tyrosine Kinase 3 Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global FMS-like Tyrosine Kinase 3 Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global FMS-like Tyrosine Kinase 3 Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global FMS-like Tyrosine Kinase 3 Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. Astellas Pharma Inc Company Information
Table 71. Astellas Pharma Inc Description and Business Overview
Table 72. Astellas Pharma Inc FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Astellas Pharma Inc FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 74. Astellas Pharma Inc Recent Developments/Updates
Table 75. Novartis Ag Company Information
Table 76. Novartis Ag Description and Business Overview
Table 77. Novartis Ag FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Ag FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 79. Novartis Ag Recent Developments/Updates
Table 80. Pfizer Inc Company Information
Table 81. Pfizer Inc Description and Business Overview
Table 82. Pfizer Inc FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer Inc FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 84. Pfizer Inc Recent Developments/Updates
Table 85. Daiichi Sanyo Company Limited Company Information
Table 86. Daiichi Sanyo Company Limited Description and Business Overview
Table 87. Daiichi Sanyo Company Limited FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Daiichi Sanyo Company Limited FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 89. Daiichi Sanyo Company Limited Recent Developments/Updates
Table 90. Cullinan Oncology Inc Company Information
Table 91. Cullinan Oncology Inc Description and Business Overview
Table 92. Cullinan Oncology Inc FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Cullinan Oncology Inc FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 94. Cullinan Oncology Inc Recent Developments/Updates
Table 95. Arog Pharmaceutials Inc Company Information
Table 96. Arog Pharmaceutials Inc Description and Business Overview
Table 97. Arog Pharmaceutials Inc FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Arog Pharmaceutials Inc FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 99. Arog Pharmaceutials Inc Recent Developments/Updates
Table 100. Aptose Biosciences Inc Company Information
Table 101. Aptose Biosciences Inc Description and Business Overview
Table 102. Aptose Biosciences Inc FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Aptose Biosciences Inc FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 104. Aptose Biosciences Inc Recent Developments/Updates
Table 105. Fujfilm Pharmaceuticals Usa Inc Company Information
Table 106. Fujfilm Pharmaceuticals Usa Inc Description and Business Overview
Table 107. Fujfilm Pharmaceuticals Usa Inc FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Fujfilm Pharmaceuticals Usa Inc FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 109. Fujfilm Pharmaceuticals Usa Inc Recent Developments/Updates
Table 110. Cspc Pharmaceutical Group Limited Company Information
Table 111. Cspc Pharmaceutical Group Limited Description and Business Overview
Table 112. Cspc Pharmaceutical Group Limited FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cspc Pharmaceutical Group Limited FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 114. Cspc Pharmaceutical Group Limited Recent Developments/Updates
Table 115. Allarity Therapeutics Inc Company Information
Table 116. Allarity Therapeutics Inc Description and Business Overview
Table 117. Allarity Therapeutics Inc FMS-like Tyrosine Kinase 3 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Allarity Therapeutics Inc FMS-like Tyrosine Kinase 3 Inhibitors Product
Table 119. Allarity Therapeutics Inc Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. FMS-like Tyrosine Kinase 3 Inhibitors Distributors List
Table 123. FMS-like Tyrosine Kinase 3 Inhibitors Customers List
Table 124. FMS-like Tyrosine Kinase 3 Inhibitors Market Trends
Table 125. FMS-like Tyrosine Kinase 3 Inhibitors Market Drivers
Table 126. FMS-like Tyrosine Kinase 3 Inhibitors Market Challenges
Table 127. FMS-like Tyrosine Kinase 3 Inhibitors Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of FMS-like Tyrosine Kinase 3 Inhibitors
Figure 2. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Type 1 Fms-like Tyrosine Kinase 3 Inhibitors Product Picture
Figure 5. Type 2 Fms-like Tyrosine Kinase 3 Inhibitors Product Picture
Figure 6. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Biology Laboratory
Figure 10. Others
Figure 11. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 13. Global FMS-like Tyrosine Kinase 3 Inhibitors Sales (2020-2031) & (K Units)
Figure 14. Global FMS-like Tyrosine Kinase 3 Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 15. FMS-like Tyrosine Kinase 3 Inhibitors Report Years Considered
Figure 16. FMS-like Tyrosine Kinase 3 Inhibitors Sales Share by Manufacturers in 2024
Figure 17. Global FMS-like Tyrosine Kinase 3 Inhibitors Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest FMS-like Tyrosine Kinase 3 Inhibitors Players: Market Share by Revenue in FMS-like Tyrosine Kinase 3 Inhibitors in 2024
Figure 19. FMS-like Tyrosine Kinase 3 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global FMS-like Tyrosine Kinase 3 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Country (2020-2031)
Figure 22. North America FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 23. United States FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Country (2020-2031)
Figure 26. Europe FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 27. Germany FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 34. China FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Country (2020-2031)
Figure 42. Latin America FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 43. Mexico FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa FMS-like Tyrosine Kinase 3 Inhibitors Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa FMS-like Tyrosine Kinase 3 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 48. Turkey FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE FMS-like Tyrosine Kinase 3 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of FMS-like Tyrosine Kinase 3 Inhibitors by Type (2020-2031)
Figure 52. Global Revenue Market Share of FMS-like Tyrosine Kinase 3 Inhibitors by Type (2020-2031)
Figure 53. Global FMS-like Tyrosine Kinase 3 Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of FMS-like Tyrosine Kinase 3 Inhibitors by Application (2020-2031)
Figure 55. Global Revenue Market Share of FMS-like Tyrosine Kinase 3 Inhibitors by Application (2020-2031)
Figure 56. Global FMS-like Tyrosine Kinase 3 Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 57. FMS-like Tyrosine Kinase 3 Inhibitors Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
